Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-04

FDA Approved: TEMBEXA — Original Application (Emergent BioDefense Operations Lansing LLC)

View source ↗

Summary

FDA approves TEMBEXA (brincidofovir) from Emergent BioDefense Operations Lansing LLC under an original application for the prevention of smallpox in at-risk pop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TEMBEXA (BRINCIDOFOVIR)

Snippet

ORIG AP for TEMBEXA (BRINCIDOFOVIR)